Search All UT System Experts

A phase I/II open label study of the safely and efficacy of an anti-ICAM-1 (intercellular adhesion molecule-1; CD54) monoclonal antibody in early rheumatoid arthritis

Arthur F. Kavanaugh, Laurie S. Davis, Rita I. Jain, Lisa A. Nichols, Steven H. Norris, Peter E. Lipsky

Research output: Contribution to journal › Article › peer-review

129 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I/II open label study of the safely and efficacy of an anti-ICAM-1 (intercellular adhesion molecule-1; CD54) monoclonal antibody in early rheumatoid arthritis'. Together they form a unique fingerprint.

Medicine & Life Sciences